- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/28 - 1,2,4-ThiadiazinesHydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
Patent holdings for IPC class C07D 285/28
Total number of patents in this class: 14
10-year publication summary
|
0
|
1
|
0
|
2
|
1
|
1
|
0
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Intellectual Property Development Limited | 742 |
1 |
| University of Florida Research Foundation, Inc. | 3968 |
1 |
| Alembic Limited | 66 |
1 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
1 |
| Les Laboratoires Servier | 596 |
1 |
| Ospedale San Raffaele S.r.l. | 261 |
1 |
| Rhythm Pharmaceuticals, Inc. | 62 |
1 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 808 |
1 |
| Theaprin Pharmaceuticals Inc. | 34 |
1 |
| Zaklady Farmaceutyczne Polpharma S.A. | 61 |
1 |
| Irbm S.p.A. | 21 |
1 |
| Promidis S.r.l. | 5 |
1 |
| Rhythm Pharmaceuticals Netherlands B.V. | 1 |
1 |
| Xinvento B.V. | 1 |
1 |
| Other owners | 0 |